Genetic Editing of HBV DNA by Monodomain Human APOBEC3 Cytidine Deaminases and the Recombinant Nature of APOBEC3G

Michel Henry, Denise Guétard, Rodolphe Suspène et al. · 2009

Read Genetic Editing of HBV DNA by Monodomain Human APOBEC3 Cytidine Deaminases and the Recombinant Nature of APOBEC3G by Michel Henry, Denise Guétard, Rodolphe Suspène et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0004277.txt.

Description

Michel Henry and colleagues published this hepatitis B study in PLOS ONE in 2009. Hepatitis B virus DNA is vulnerable to editing by human APOBEC3 cytidine deaminases. These enzymes mutate viral DNA, though HBV is edited far less than HIV. The team analysed and compared editing by all seven APOBEC3 enzymes.

Using a quail cell line that makes no APOBEC of its own, they tested single-domain versions of each enzyme against HBV. They examined the recombinant nature of APOBEC3G, the family's best-known member. Mapping which enzymes can edit HBV clarifies a natural defence the virus must dodge.

Catalog record

CREATORMichel Henry, Denise Guétard, Rodolphe Suspène et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE50 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0004277

Browse the full library · About the Tower of Babel